{
  "data": [
    {
      "PCERDocID": "PCER000013815",
      "_id": "AlleleRecords/1692876078",
      "_key": "1692876078",
      "_rev": "_md_ZeJO---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA224451",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97105",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.106C>T",
        "NC_000023.11:g.38367319C>T",
        "CM000685.2:g.38367319C>T",
        "NC_000023.10:g.38226572C>T",
        "CM000685.1:g.38226572C>T",
        "NC_000023.9:g.38111516C>T",
        "NG_008471.1:g.19837C>T",
        "ENST00000039007.5:c.106C>T",
        "ENST00000643344.1:c.106C>T",
        "ENST00000039007.4:c.106C>T",
        "ENST00000465127.1:c.172-298802C>T",
        "ENST00000488812.1:n.198C>T",
        "NM_000531.5:c.106C>T",
        "XM_017029556.1:c.106C>T",
        "NM_000531.6(OTC):c.106C>T (p.Gln36Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.106c>t nc_000023.11:g.38367319c>t cm000685.2:g.38367319c>t nc_000023.10:g.38226572c>t cm000685.1:g.38226572c>t nc_000023.9:g.38111516c>t ng_008471.1:g.19837c>t enst00000039007.5:c.106c>t enst00000643344.1:c.106c>t enst00000039007.4:c.106c>t enst00000465127.1:c.172-298802c>t enst00000488812.1:n.198c>t nm_000531.5:c.106c>t xm_017029556.1:c.106c>t nm_000531.6(otc):c.106c>t (p.gln36ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.106C>T (p.Gln36Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.106C>T variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "84152d17-f73e-4799-a328-db7c53e6acfb",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013816",
      "_id": "AlleleRecords/1692877803",
      "_key": "1692877803",
      "_rev": "_md_h6Ka---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233316",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.630del",
        "NC_000023.11:g.38403707del",
        "CM000685.2:g.38403707del",
        "NC_000023.10:g.38262960del",
        "CM000685.1:g.38262960del",
        "NC_000023.9:g.38147904del",
        "NG_008471.1:g.56225del",
        "ENST00000039007.5:c.630del",
        "ENST00000643344.1:c.*380del",
        "ENST00000039007.4:c.630del",
        "ENST00000465127.1:c.172-262414del",
        "NM_000531.5:c.630del",
        "XM_017029556.1:c.630del"
      ],
      "hgvsSearch": "nm_000531.6:c.630del nc_000023.11:g.38403707del cm000685.2:g.38403707del nc_000023.10:g.38262960del cm000685.1:g.38262960del nc_000023.9:g.38147904del ng_008471.1:g.56225del enst00000039007.5:c.630del enst00000643344.1:c.*380del enst00000039007.4:c.630del enst00000465127.1:c.172-262414del nm_000531.5:c.630del xm_017029556.1:c.630del",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.630del",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.630del (p.Lys210AsnfsTer20) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 6/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1), total +9.",
      "uuid": "126fbce8-5d3a-489f-8193-80f840d4ec06",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013817",
      "_id": "AlleleRecords/1692879745",
      "_key": "1692879745",
      "_rev": "_md_qWLu---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233327",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.799dup",
        "NC_000023.11:g.38408957dup",
        "CM000685.2:g.38408957dup",
        "NC_000023.10:g.38268210dup",
        "CM000685.1:g.38268210dup",
        "NC_000023.9:g.38153154dup",
        "NG_008471.1:g.61475dup",
        "ENST00000039007.5:c.799dup",
        "ENST00000643344.1:c.*549dup",
        "ENST00000039007.4:c.799dup",
        "ENST00000465127.1:c.172-257164dup",
        "NM_000531.5:c.799dup",
        "XM_017029556.1:c.799dup"
      ],
      "hgvsSearch": "nm_000531.6:c.799dup nc_000023.11:g.38408957dup cm000685.2:g.38408957dup nc_000023.10:g.38268210dup cm000685.1:g.38268210dup nc_000023.9:g.38153154dup ng_008471.1:g.61475dup enst00000039007.5:c.799dup enst00000643344.1:c.*549dup enst00000039007.4:c.799dup enst00000465127.1:c.172-257164dup nm_000531.5:c.799dup xm_017029556.1:c.799dup",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.799dup",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.799dup (p.Ser267LysfsTer26) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 8/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "588a994e-78a0-4345-a2a8-8f88ecd9732f",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013818",
      "_id": "AlleleRecords/1692881123",
      "_key": "1692881123",
      "_rev": "_md_yye----",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA2695233305",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.461_471del",
        "NC_000023.11:g.38401349_38401359del",
        "CM000685.2:g.38401349_38401359del",
        "NC_000023.10:g.38260602_38260612del",
        "CM000685.1:g.38260602_38260612del",
        "NC_000023.9:g.38145546_38145556del",
        "NG_008471.1:g.53867_53877del",
        "ENST00000039007.5:c.461_471del",
        "ENST00000643344.1:c.*211_*221del",
        "ENST00000039007.4:c.461_471del",
        "ENST00000465127.1:c.172-264772_172-264762del",
        "ENST00000488812.1:n.498_508del",
        "NM_000531.5:c.461_471del",
        "XM_017029556.1:c.461_471del"
      ],
      "hgvsSearch": "nm_000531.6:c.461_471del nc_000023.11:g.38401349_38401359del cm000685.2:g.38401349_38401359del nc_000023.10:g.38260602_38260612del cm000685.1:g.38260602_38260612del nc_000023.9:g.38145546_38145556del ng_008471.1:g.53867_53877del enst00000039007.5:c.461_471del enst00000643344.1:c.*211_*221del enst00000039007.4:c.461_471del enst00000465127.1:c.172-264772_172-264762del enst00000488812.1:n.498_508del nm_000531.5:c.461_471del xm_017029556.1:c.461_471del",
      "metCodes": [
        "PVS1",
        "PM6_Supporting",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm6_supporting pm2_supporting pp4",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.461_471del",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.461_471del (p.Glu154AlafsTer18) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). One patient with this variant displayed neonatal onset, oroticaciduria, hyperammonemia which is highly specific for OTC deficiency (1.25pt; PP4_Supporting, PMID: 23278509). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant has been identified as a de novo occurrence with unconfirmed parental relationships in 1 individual as a de novo occurrence OTCD (PM6; PMID: 23278509). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt), PM6 (+2 pts), PP4_Supporting (+1 pt).",
      "uuid": "4be28294-4f7a-41e1-98b9-2ca38dd02333",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013819",
      "_id": "AlleleRecords/1692883587",
      "_key": "1692883587",
      "_rev": "_md_7Ovy---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA412723777",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "2573437",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.853C>T",
        "NC_000023.11:g.38409011C>T",
        "CM000685.2:g.38409011C>T",
        "NC_000023.10:g.38268264C>T",
        "CM000685.1:g.38268264C>T",
        "NC_000023.9:g.38153208C>T",
        "NG_008471.1:g.61529C>T",
        "ENST00000039007.5:c.853C>T",
        "ENST00000643344.1:c.*603C>T",
        "ENST00000039007.4:c.853C>T",
        "ENST00000465127.1:c.172-257110C>T",
        "NM_000531.5:c.853C>T",
        "XM_017029556.1:c.853C>T",
        "NM_000531.6(OTC):c.853C>T (p.Gln285Ter)"
      ],
      "hgvsSearch": "nm_000531.6:c.853c>t nc_000023.11:g.38409011c>t cm000685.2:g.38409011c>t nc_000023.10:g.38268264c>t cm000685.1:g.38268264c>t nc_000023.9:g.38153208c>t ng_008471.1:g.61529c>t enst00000039007.5:c.853c>t enst00000643344.1:c.*603c>t enst00000039007.4:c.853c>t enst00000465127.1:c.172-257110c>t nm_000531.5:c.853c>t xm_017029556.1:c.853c>t nm_000531.6(otc):c.853c>t (p.gln285ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm2_supporting pp4",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.853C>T (p.Gln285Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6:c.853C>T(p.Gln285Ter) variant in OTC is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 8 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). One patient with this variant displayed Hyperammonemia, oroticaciduria, Childhood onset which is highly specific for OTC deficiency (1.25pts; PP4_Supporting, PMID: 23278509). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt), PP4_Supporting (+1 pt).",
      "unMetCodes": [
        "PM6",
        "PS2"
      ],
      "unMetCodesSearch": "pm6 ps2",
      "uuid": "ea467d08-57b7-4634-aff0-724585f2e198",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013820",
      "_id": "AlleleRecords/1692885043",
      "_key": "1692885043",
      "_rev": "_mdADrHG---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA913190354",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "597358",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.391_397dup",
        "NC_000023.11:g.38401279_38401285dup",
        "CM000685.2:g.38401279_38401285dup",
        "NC_000023.10:g.38260532_38260538dup",
        "CM000685.1:g.38260532_38260538dup",
        "NC_000023.9:g.38145476_38145482dup",
        "NG_008471.1:g.53797_53803dup",
        "ENST00000039007.5:c.391_397dup",
        "ENST00000643344.1:c.*141_*147dup",
        "ENST00000039007.4:c.391_397dup",
        "ENST00000465127.1:c.172-264842_172-264836dup",
        "ENST00000488812.1:n.428_434dup",
        "NM_000531.5:c.391_397dup",
        "XM_017029556.1:c.391_397dup"
      ],
      "hgvsSearch": "nm_000531.6:c.391_397dup nc_000023.11:g.38401279_38401285dup cm000685.2:g.38401279_38401285dup nc_000023.10:g.38260532_38260538dup cm000685.1:g.38260532_38260538dup nc_000023.9:g.38145476_38145482dup ng_008471.1:g.53797_53803dup enst00000039007.5:c.391_397dup enst00000643344.1:c.*141_*147dup enst00000039007.4:c.391_397dup enst00000465127.1:c.172-264842_172-264836dup enst00000488812.1:n.428_434dup nm_000531.5:c.391_397dup xm_017029556.1:c.391_397dup",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.391_397dup",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.391_397dup (p.Ser133IlefsTer3) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). One patient with this variant displayed orotic aciduria, hyperglutaminemia, hyperammonemia, childhood onset of the disease, low plasma citrulline, which is highly specific for OTC deficiency (1.75pt; PP4_Moderate, PMID: 17334707). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+ 1 pt), PP4_Moderate (+2 pts).",
      "uuid": "8cdf5f38-3715-4f91-a350-af59f91ec0ff",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013821",
      "_id": "AlleleRecords/1692886689",
      "_key": "1692886689",
      "_rev": "_mdAMIW6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-17",
      "caId": "CA224771",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97311",
      "docVersion": "1.0.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.759del",
        "NC_000023.11:g.38408917del",
        "CM000685.2:g.38408917del",
        "NC_000023.10:g.38268170del",
        "CM000685.1:g.38268170del",
        "NC_000023.9:g.38153114del",
        "NG_008471.1:g.61435del",
        "ENST00000039007.5:c.759del",
        "ENST00000643344.1:c.*509del",
        "ENST00000039007.4:c.759del",
        "ENST00000465127.1:c.172-257204del",
        "NM_000531.5:c.759del",
        "XM_017029556.1:c.759del",
        "NM_000531.6(OTC):c.759del (p.Ala254fs)"
      ],
      "hgvsSearch": "nm_000531.6:c.759del nc_000023.11:g.38408917del cm000685.2:g.38408917del nc_000023.10:g.38268170del cm000685.1:g.38268170del nc_000023.9:g.38153114del ng_008471.1:g.61435del enst00000039007.5:c.759del enst00000643344.1:c.*509del enst00000039007.4:c.759del enst00000465127.1:c.172-257204del nm_000531.5:c.759del xm_017029556.1:c.759del nm_000531.6(otc):c.759del (p.ala254fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.759del (p.Ala254fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.759del (p.Ala254ArgfsTer7) variant in OTC is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 8/10 for OTC leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8 pts), PM2_Supporting (+1 pt).",
      "uuid": "a754c0e2-28ed-4b71-9b5f-6b28a2600911",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013822",
      "_id": "AlleleRecords/1692888166",
      "_key": "1692888166",
      "_rev": "_mdAUlCC---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3203994",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "853579",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.4360C>T",
        "NC_000005.10:g.13864633G>A",
        "CM000667.2:g.13864633G>A",
        "NC_000005.9:g.13864742G>A",
        "CM000667.1:g.13864742G>A",
        "NC_000005.8:g.13917742G>A",
        "NG_013081.1:g.84848C>T",
        "NG_013081.2:g.84848C>T",
        "ENST00000265104.5:c.4360C>T",
        "ENST00000681290.1:c.4315C>T",
        "ENST00000265104.4:c.4360C>T",
        "NM_001369.2:c.4360C>T",
        "XM_005248262.2:c.4315C>T",
        "XM_011513990.1:c.4360C>T",
        "XR_925598.1:n.4567C>T",
        "XM_005248262.3:c.4468C>T",
        "XM_017009177.1:c.4468C>T",
        "XM_017009178.1:c.3373C>T",
        "XM_017009179.2:c.3373C>T",
        "XM_017009180.1:c.4468C>T",
        "XM_017009181.1:c.4468C>T",
        "XM_017009182.1:c.4468C>T",
        "XM_017009183.1:c.4468C>T",
        "XM_017009184.1:c.4468C>T",
        "XM_017009187.1:c.4468C>T",
        "XM_024454388.1:c.3373C>T",
        "XM_024454389.1:c.2962C>T",
        "XR_001742034.1:n.4485C>T",
        "XR_001742035.1:n.4485C>T",
        "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.4360c>t nc_000005.10:g.13864633g>a cm000667.2:g.13864633g>a nc_000005.9:g.13864742g>a cm000667.1:g.13864742g>a nc_000005.8:g.13917742g>a ng_013081.1:g.84848c>t ng_013081.2:g.84848c>t enst00000265104.5:c.4360c>t enst00000681290.1:c.4315c>t enst00000265104.4:c.4360c>t nm_001369.2:c.4360c>t xm_005248262.2:c.4315c>t xm_011513990.1:c.4360c>t xr_925598.1:n.4567c>t xm_005248262.3:c.4468c>t xm_017009177.1:c.4468c>t xm_017009178.1:c.3373c>t xm_017009179.2:c.3373c>t xm_017009180.1:c.4468c>t xm_017009181.1:c.4468c>t xm_017009182.1:c.4468c>t xm_017009183.1:c.4468c>t xm_017009184.1:c.4468c>t xm_017009187.1:c.4468c>t xm_024454388.1:c.3373c>t xm_024454389.1:c.2962c>t xr_001742034.1:n.4485c>t xr_001742035.1:n.4485c>t nm_001369.3(dnah5):c.4360c>t (p.arg1454ter)",
      "metCodes": [
        "PVS1",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pvs1 pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.4360C>T (p.Arg1454Ter) is a nonsense variant that introduces a premature stop codon into exon 28 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v4.1.1 at a Grpmax allele frequency of 0.00001062, with 3 alleles / 75,022 total alleles in the African / African American population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00008426 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant has been found in the homozygous state in one occurrence in gnomAD v4.1.0, in the Finnish population, however, at least three occurrences in gnomAD are required to meet BS2. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9346C>T (p.Arg3116Ter) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 total point, PMID: 38206729, PM3). The proband harboring this variant exhibits a phenotype including onset at age 3 years, family history consistent with autosomal recessive inheritance, recurrent wet cough (1 pt), absence of outer dynein arms in ciliary axonemes (4 pts), recurrent respiratory infections including sinusitis (1 pt) with purulent rhinorrhea, bilateral pneumonia, bronchiectasis (1 pt), and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 38206729, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS2"
      ],
      "unMetCodesSearch": "pm2 bs2",
      "uuid": "d8fbd409-0580-4cf4-83a1-ec53714c30a8",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013823",
      "_id": "AlleleRecords/1692892443",
      "_key": "1692892443",
      "_rev": "_mdAtdly---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA339772",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "65636",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.10815delT",
        "NM_001369.3:c.10815del",
        "NC_000005.10:g.13753290del",
        "CM000667.2:g.13753290del",
        "NC_000005.9:g.13753399del",
        "CM000667.1:g.13753399del",
        "NC_000005.8:g.13806399del",
        "NG_013081.1:g.196191del",
        "NG_013081.2:g.196191del",
        "ENST00000265104.5:c.10815del",
        "ENST00000681290.1:c.10770del",
        "ENST00000265104.4:c.10815del",
        "NM_001369.2:c.10815del",
        "XM_005248262.2:c.10770del",
        "XM_005248262.3:c.10923del",
        "XM_017009177.1:c.10923del",
        "XM_017009178.1:c.9828del",
        "XM_017009179.2:c.9828del",
        "XM_017009180.1:c.10923del",
        "XM_017009181.1:c.10923del",
        "XM_017009182.1:c.10923del",
        "XM_017009185.1:c.6012del",
        "XM_017009186.1:c.5565del",
        "XM_017009188.1:c.4902del",
        "XM_024454388.1:c.9828del",
        "XM_024454389.1:c.9417del",
        "NM_001369.3(DNAH5):c.10815del (p.Pro3606fs)"
      ],
      "hgvsSearch": "nm_001369.3:c.10815delt nm_001369.3:c.10815del nc_000005.10:g.13753290del cm000667.2:g.13753290del nc_000005.9:g.13753399del cm000667.1:g.13753399del nc_000005.8:g.13806399del ng_013081.1:g.196191del ng_013081.2:g.196191del enst00000265104.5:c.10815del enst00000681290.1:c.10770del enst00000265104.4:c.10815del nm_001369.2:c.10815del xm_005248262.2:c.10770del xm_005248262.3:c.10923del xm_017009177.1:c.10923del xm_017009178.1:c.9828del xm_017009179.2:c.9828del xm_017009180.1:c.10923del xm_017009181.1:c.10923del xm_017009182.1:c.10923del xm_017009185.1:c.6012del xm_017009186.1:c.5565del xm_017009188.1:c.4902del xm_024454388.1:c.9828del xm_024454389.1:c.9417del nm_001369.3(dnah5):c.10815del (p.pro3606fs)",
      "metCodes": [
        "PVS1",
        "PM3_Supporting",
        "PP1",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm3_supporting pp1 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.10815del (p.Pro3606fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.10815del (p.Pro3606HisfsTer23) is a frameshift variant that introduces a premature stop codon into exon 63 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1, PMIDs: 16627867, 34556108). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.00051, with 638 alleles / 1,179,900 total alleles in the European (non-Finnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.000411 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was homozygous for the variant (0.5 points, PMID: 16627867, PMID: 20301301, PM3_Supporting). This variant has also been reported in at least 4 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.232C>T (p.Arg78Ter) variant confirmed in trans (PMID: 16627867, PMID: 31879361), the NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) confirmed in trans (PMID: 16627867, 39115449), or the NM_001369.3:c.13486C>T (p.Arg4496Ter) (PMID: 16627867) confirmed in trans, all of which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP, which were not counted for PM3 in order to avoid circularity. At least one proband harboring this variant exhibits a phenotype including: absent outer dynein arms (4 pt), productive cough (1 pt), decreased nasal nitric oxide (1 pt), neonatal respiratory distress (1 pt), sinusitis, rhinitis, chronic otitis media (1 pt) and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 9 points, PMID:23477994, PP4). The variant has been reported to co-segregate with primary ciliary dyskinesia through at least one segregation within the family of the proband, with the variant present in the compound heterozygous state (PMID: 23477994, PP1). In summary, this variant meets the criteria to be classified as Pathogenic for primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3_Supporting, PP4, and PP1. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "8f286f60-da57-4194-9500-39f3188038b2",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013824",
      "_id": "AlleleRecords/1692893601",
      "_key": "1692893601",
      "_rev": "_mdA15wW---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA113954672",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "1458963",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5147G>T",
        "NC_000005.10:g.13844961C>A",
        "CM000667.2:g.13844961C>A",
        "NC_000005.9:g.13845070C>A",
        "CM000667.1:g.13845070C>A",
        "NC_000005.8:g.13898070C>A",
        "NG_013081.1:g.104520G>T",
        "NG_013081.2:g.104520G>T",
        "ENST00000265104.5:c.5147G>T",
        "ENST00000681290.1:c.5102G>T",
        "ENST00000265104.4:c.5147G>T",
        "NM_001369.2:c.5147G>T",
        "XM_005248262.2:c.5102G>T",
        "XM_011513990.1:c.5147G>T",
        "XR_925598.1:n.5354G>T",
        "XM_005248262.3:c.5255G>T",
        "XM_017009177.1:c.5255G>T",
        "XM_017009178.1:c.4160G>T",
        "XM_017009179.2:c.4160G>T",
        "XM_017009180.1:c.5255G>T",
        "XM_017009181.1:c.5255G>T",
        "XM_017009182.1:c.5255G>T",
        "XM_017009183.1:c.5255G>T",
        "XM_017009184.1:c.5255G>T",
        "XM_017009185.1:c.344G>T",
        "XM_017009186.1:c.22-3057G>T",
        "XM_017009187.1:c.5255G>T",
        "XM_024454388.1:c.4160G>T",
        "XM_024454389.1:c.3749G>T",
        "XR_001742034.1:n.5272G>T",
        "XR_001742035.1:n.5272G>T",
        "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu)"
      ],
      "hgvsSearch": "nm_001369.3:c.5147g>t nc_000005.10:g.13844961c>a cm000667.2:g.13844961c>a nc_000005.9:g.13845070c>a cm000667.1:g.13845070c>a nc_000005.8:g.13898070c>a ng_013081.1:g.104520g>t ng_013081.2:g.104520g>t enst00000265104.5:c.5147g>t enst00000681290.1:c.5102g>t enst00000265104.4:c.5147g>t nm_001369.2:c.5147g>t xm_005248262.2:c.5102g>t xm_011513990.1:c.5147g>t xr_925598.1:n.5354g>t xm_005248262.3:c.5255g>t xm_017009177.1:c.5255g>t xm_017009178.1:c.4160g>t xm_017009179.2:c.4160g>t xm_017009180.1:c.5255g>t xm_017009181.1:c.5255g>t xm_017009182.1:c.5255g>t xm_017009183.1:c.5255g>t xm_017009184.1:c.5255g>t xm_017009185.1:c.344g>t xm_017009186.1:c.22-3057g>t xm_017009187.1:c.5255g>t xm_024454388.1:c.4160g>t xm_024454389.1:c.3749g>t xr_001742034.1:n.5272g>t xr_001742035.1:n.5272g>t nm_001369.3(dnah5):c.5147g>t (p.arg1716leu)",
      "metCodes": [
        "PP3_Strong",
        "PM2_Supporting",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pp3_strong pm2_supporting pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5147G>T (p.Arg1716Leu) is a missense variant encoding substitution of arginine by leucine at amino acid 1716. This variant is present in gnomAD v4.1.1 at a total allele frequency of 0.0000006196, with 1 allele / 1,614,004 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 points, PMID:16627867, PM3). The proband harboring this variant exhibits a phenotype including absence of outer dynein arms by immunofluorescence (4 pts), situs inversus (1 pt), recurrent pneumonia (0.5 pt), onset of bronchiectasis in childhood before 18 years of age (1 pt) and respiratory cilia with severely altered or no motility (1 pt), which together are specific for primary ciliary dyskinesia (7.5 total points, PMID: 16627867, PP4). The computational predictor REVEL gives a score of 0.954, which is above the ClinGen Motile Ciliopathy VCEP threshold of ≥0.932 and predicts a damaging effect on DNAH5 function (PP3_Strong). The splicing impact predictor SpliceAI gives delta scores of 0.35 for acceptor gain and 0.29 for acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predicts a damaging impact on DNAH5 splicing. Another missense variant in the same codon, NM_001369.3(DNAH5):c.5146C>T (p.Arg1716Trp), has been classified as likely pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 36864285, PMID: 32502479). Splicing prediction using SpliceAI predicted an effect on splicing for this variant that was not predicted for the previous variant, so PM5_Supporting has not been counted. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PM2_Supporting, PM3, PP4, and PP3_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM5"
      ],
      "unMetCodesSearch": "pm5",
      "uuid": "da4b884e-85d2-44dd-b8f9-6858be7ce871",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013825",
      "_id": "AlleleRecords/1692895055",
      "_key": "1692895055",
      "_rev": "_mdB-W8i---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA359214371",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "934373",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5147G>C",
        "NC_000005.10:g.13844961C>G",
        "CM000667.2:g.13844961C>G",
        "NC_000005.9:g.13845070C>G",
        "CM000667.1:g.13845070C>G",
        "NC_000005.8:g.13898070C>G",
        "NG_013081.1:g.104520G>C",
        "NG_013081.2:g.104520G>C",
        "ENST00000265104.5:c.5147G>C",
        "ENST00000681290.1:c.5102G>C",
        "ENST00000265104.4:c.5147G>C",
        "NM_001369.2:c.5147G>C",
        "XM_005248262.2:c.5102G>C",
        "XM_011513990.1:c.5147G>C",
        "XR_925598.1:n.5354G>C",
        "XM_005248262.3:c.5255G>C",
        "XM_017009177.1:c.5255G>C",
        "XM_017009178.1:c.4160G>C",
        "XM_017009179.2:c.4160G>C",
        "XM_017009180.1:c.5255G>C",
        "XM_017009181.1:c.5255G>C",
        "XM_017009182.1:c.5255G>C",
        "XM_017009183.1:c.5255G>C",
        "XM_017009184.1:c.5255G>C",
        "XM_017009185.1:c.344G>C",
        "XM_017009186.1:c.22-3057G>C",
        "XM_017009187.1:c.5255G>C",
        "XM_024454388.1:c.4160G>C",
        "XM_024454389.1:c.3749G>C",
        "XR_001742034.1:n.5272G>C",
        "XR_001742035.1:n.5272G>C",
        "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro)"
      ],
      "hgvsSearch": "nm_001369.3:c.5147g>c nc_000005.10:g.13844961c>g cm000667.2:g.13844961c>g nc_000005.9:g.13845070c>g cm000667.1:g.13845070c>g nc_000005.8:g.13898070c>g ng_013081.1:g.104520g>c ng_013081.2:g.104520g>c enst00000265104.5:c.5147g>c enst00000681290.1:c.5102g>c enst00000265104.4:c.5147g>c nm_001369.2:c.5147g>c xm_005248262.2:c.5102g>c xm_011513990.1:c.5147g>c xr_925598.1:n.5354g>c xm_005248262.3:c.5255g>c xm_017009177.1:c.5255g>c xm_017009178.1:c.4160g>c xm_017009179.2:c.4160g>c xm_017009180.1:c.5255g>c xm_017009181.1:c.5255g>c xm_017009182.1:c.5255g>c xm_017009183.1:c.5255g>c xm_017009184.1:c.5255g>c xm_017009185.1:c.344g>c xm_017009186.1:c.22-3057g>c xm_017009187.1:c.5255g>c xm_024454388.1:c.4160g>c xm_024454389.1:c.3749g>c xr_001742034.1:n.5272g>c xr_001742035.1:n.5272g>c nm_001369.3(dnah5):c.5147g>c (p.arg1716pro)",
      "metCodes": [
        "PP3_Strong",
        "PM3_Supporting",
        "PM2_Supporting",
        "PP4"
      ],
      "metCodesSearch": "pp3_strong pm3_supporting pm2_supporting pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5147G>C (p.Arg1716Pro) is a missense variant encoding substitution of arginine by proline at amino acid 1716. This variant is absent from gnomAD v4.1.1 (PM2_Supporting). This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9799C>T (p.Gln3267Ter) variant suspected but not confirmed in trans, which was previously classified pathogenic by the Motile Ciliopathy VCEP (0.5 points, PMID: 30067075, PM3_Supporting). The proband harboring this variant exhibits a phenotype including an outer dynein defect (4 pts) and other clinical details confirmed through confidential correspondence, which together are specific for primary ciliary dyskinesia 3 (total 6 points, PMID: 30067075, PP4). The computational predictor REVEL gives a score of 0.973, which is above the ClinGen Motile Ciliopathy VCEP threshold of ≥0.932 and predicts a damaging effect on DNAH5 function (PP3_Strong). The splicing impact predictor SpliceAI gives a delta score of 0.13 for acceptor gain, which is below the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and does not strongly predict a damaging impact on DNAH5 splicing. Another missense variant in the same codon, NM_001369.3(DNAH5):c.5146C>T (p.Arg1716Trp), has been classified as likely pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 36864285, PMID: 32502479). Splicing prediction using SpliceAI did not strongly predict an effect on splicing due to either of these variants. However, PM5_Supporting was not counted as this code is mutually exclusive with PP3_Strong. In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PM2_Supporting, PP4, PM3_Supporting, and PP3_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM5"
      ],
      "unMetCodesSearch": "pm5",
      "uuid": "e9e4da4d-6caf-440f-8c5a-90ba9607370d",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013826",
      "_id": "AlleleRecords/1692896931",
      "_key": "1692896931",
      "_rev": "_mdBGzW2---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3201398",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "572293",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.13338+5G>A",
        "NC_000005.10:g.13708118C>T",
        "CM000667.2:g.13708118C>T",
        "NC_000005.9:g.13708227C>T",
        "CM000667.1:g.13708227C>T",
        "NC_000005.8:g.13761227C>T",
        "NG_013081.1:g.241363G>A",
        "NG_013081.2:g.241363G>A",
        "ENST00000683611.1:n.671+5G>A",
        "ENST00000265104.5:c.13338+5G>A",
        "ENST00000681290.1:c.13293+5G>A",
        "ENST00000265104.4:c.13338+5G>A",
        "NM_001369.2:c.13338+5G>A",
        "XM_005248262.2:c.13293+5G>A",
        "XM_005248262.3:c.13446+5G>A",
        "XM_017009177.1:c.13026+5G>A",
        "XM_017009178.1:c.12351+5G>A",
        "XM_017009179.2:c.12351+5G>A",
        "XM_017009185.1:c.8535+5G>A",
        "XM_017009186.1:c.8088+5G>A",
        "XM_017009188.1:c.7425+5G>A",
        "XM_024454388.1:c.12351+5G>A",
        "XM_024454389.1:c.11940+5G>A",
        "NM_001369.3(DNAH5):c.13338+5G>A"
      ],
      "hgvsSearch": "nm_001369.3:c.13338+5g>a nc_000005.10:g.13708118c>t cm000667.2:g.13708118c>t nc_000005.9:g.13708227c>t cm000667.1:g.13708227c>t nc_000005.8:g.13761227c>t ng_013081.1:g.241363g>a ng_013081.2:g.241363g>a enst00000683611.1:n.671+5g>a enst00000265104.5:c.13338+5g>a enst00000681290.1:c.13293+5g>a enst00000265104.4:c.13338+5g>a nm_001369.2:c.13338+5g>a xm_005248262.2:c.13293+5g>a xm_005248262.3:c.13446+5g>a xm_017009177.1:c.13026+5g>a xm_017009178.1:c.12351+5g>a xm_017009179.2:c.12351+5g>a xm_017009185.1:c.8535+5g>a xm_017009186.1:c.8088+5g>a xm_017009188.1:c.7425+5g>a xm_024454388.1:c.12351+5g>a xm_024454389.1:c.11940+5g>a nm_001369.3(dnah5):c.13338+5g>a",
      "metCodes": [
        "PM2_Supporting",
        "PS1",
        "PM3_Strong",
        "PP3",
        "PP4"
      ],
      "metCodesSearch": "pm2_supporting ps1 pm3_strong pp3 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.13338+5G>A",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.13338+5G>A is an intronic variant located outside of the canonical splice site at the +5 nucleotide position of the donor splice region downstream of exon 76. The splicing impact predictor SpliceAI gives delta scores of 0.92 for splice donor loss and 0.84 for splice acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predict a damaging impact on DNAH5 splicing (PP3). Another intronic variant in the same nucleotide position, NM_001369.3(DNAH5):c.13338+5G>C, has been classified pathogenic for primary ciliary dyskinesia 3 by the ClinGen Motile Ciliopathy VCEP (PMID: 39014333, PS1). This variant is present in gnomAD v4.1.1 at a total allele frequency of 0.00001177, with 19 alleles / 1,613,716 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 3 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.5563dup (p.Ile1855AsnfsTer6) variant confirmed in trans (PMID:16627867, personal communication), or the NM_001369.3(DNAH5):c.10384C>T (p.Gln3462Ter) variant suspected but not confirmed in trans (found in two unrelated probands, PMID: 24498942, PMID:  29363216), both of which were previously classified as pathogenic by the ClinGen Motile Ciliopathy VCEP (total 2 pts, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including absent outer dynein arms by transmission electron microscopy (4 pt), neonatal respiratory distress (1 pt), recurrent pneumonia (0.5 pt), bronchiectasis with undetermined age of onset (0.5 pt), sinusitis and chronic otitis media (1 pt), and situs inversus totalis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 16627867, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PP3, PS1, PM2_Supporting, PM3_Strong, and PP4. (VCEP specifications version 1.0.0).",
      "uuid": "be90e8d5-d17c-4395-b095-bfb549518b05",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013827",
      "_id": "AlleleRecords/1692898211",
      "_key": "1692898211",
      "_rev": "_mdBPQBa---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3203638",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "407241",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.5563dup",
        "NC_000005.10:g.13841058dup",
        "CM000667.2:g.13841058dup",
        "NC_000005.9:g.13841167dup",
        "CM000667.1:g.13841167dup",
        "NC_000005.8:g.13894167dup",
        "NG_013081.1:g.108429dup",
        "NG_013081.2:g.108429dup",
        "ENST00000265104.5:c.5563dup",
        "ENST00000681290.1:c.5518dup",
        "ENST00000265104.4:c.5563dup",
        "NM_001369.2:c.5563dup",
        "XM_005248262.2:c.5518dup",
        "XM_011513990.1:c.5563dup",
        "XR_925598.1:n.5770dup",
        "XM_005248262.3:c.5671dup",
        "XM_017009177.1:c.5671dup",
        "XM_017009178.1:c.4576dup",
        "XM_017009179.2:c.4576dup",
        "XM_017009180.1:c.5671dup",
        "XM_017009181.1:c.5671dup",
        "XM_017009182.1:c.5671dup",
        "XM_017009183.1:c.5671dup",
        "XM_017009184.1:c.5671dup",
        "XM_017009185.1:c.760dup",
        "XM_017009186.1:c.313dup",
        "XM_017009187.1:c.5671dup",
        "XM_024454388.1:c.4576dup",
        "XM_024454389.1:c.4165dup",
        "XR_001742034.1:n.5688dup",
        "XR_001742035.1:n.5688dup",
        "NM_001369.3(DNAH5):c.5563dup (p.Ile1855fs)"
      ],
      "hgvsSearch": "nm_001369.3:c.5563dup nc_000005.10:g.13841058dup cm000667.2:g.13841058dup nc_000005.9:g.13841167dup cm000667.1:g.13841167dup nc_000005.8:g.13894167dup ng_013081.1:g.108429dup ng_013081.2:g.108429dup enst00000265104.5:c.5563dup enst00000681290.1:c.5518dup enst00000265104.4:c.5563dup nm_001369.2:c.5563dup xm_005248262.2:c.5518dup xm_011513990.1:c.5563dup xr_925598.1:n.5770dup xm_005248262.3:c.5671dup xm_017009177.1:c.5671dup xm_017009178.1:c.4576dup xm_017009179.2:c.4576dup xm_017009180.1:c.5671dup xm_017009181.1:c.5671dup xm_017009182.1:c.5671dup xm_017009183.1:c.5671dup xm_017009184.1:c.5671dup xm_017009185.1:c.760dup xm_017009186.1:c.313dup xm_017009187.1:c.5671dup xm_024454388.1:c.4576dup xm_024454389.1:c.4165dup xr_001742034.1:n.5688dup xr_001742035.1:n.5688dup nm_001369.3(dnah5):c.5563dup (p.ile1855fs)",
      "metCodes": [
        "PVS1",
        "PP1_Strong",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pp1_strong pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.5563dup (p.Ile1855fs)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.5563dup (p.Ile1855AsnfsTer6) is a frameshift variant that introduces a premature stop codon into exon 34 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.0003497, with 23 alleles / 44,884 total alleles in the East Asian population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00006010 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. At least one proband harboring this variant exhibits a phenotype including chronic sinusitis and otitis media (1 pt, PMID: 11062149), absence of the outer dynein arms (4 pt, required), early onset bronchiectasis (1 pt), immotile cilia (1 pt), and situs inversus (1 pt), which together are specific for primary ciliary dyskinesia 3 (8 points, PMID: 11788826, PP4).The variant has been reported to co-segregate with primary ciliary dyskinesia through at least three segregations within the family of the proband, with the variant present in the homozygous state (PP1_Strong; PMID: 11788826). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PP4, and PP1_Strong. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2"
      ],
      "unMetCodesSearch": "pm2",
      "uuid": "8cf7e7ce-129c-433d-87dc-7a4d02f8d3c3",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013828",
      "_id": "AlleleRecords/1692899335",
      "_key": "1692899335",
      "_rev": "_mdBXsem---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA3201359",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "350995",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.13458dup",
        "NC_000005.10:g.13701323dup",
        "CM000667.2:g.13701323dup",
        "NC_000005.9:g.13701432dup",
        "CM000667.1:g.13701432dup",
        "NC_000005.8:g.13754432dup",
        "NG_013081.1:g.248164dup",
        "NG_013081.2:g.248164dup",
        "ENST00000683611.1:n.791dup",
        "ENST00000265104.5:c.13458dup",
        "ENST00000681290.1:c.13413dup",
        "ENST00000265104.4:c.13458dup",
        "NM_001369.2:c.13458dup",
        "XM_005248262.2:c.13413dup",
        "XM_005248262.3:c.13566dup",
        "XM_017009177.1:c.13146dup",
        "XM_017009178.1:c.12471dup",
        "XM_017009179.2:c.12471dup",
        "XM_017009185.1:c.8655dup",
        "XM_017009186.1:c.8208dup",
        "XM_017009188.1:c.7545dup",
        "XM_024454388.1:c.12471dup",
        "XM_024454389.1:c.12060dup",
        "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.13458dup nc_000005.10:g.13701323dup cm000667.2:g.13701323dup nc_000005.9:g.13701432dup cm000667.1:g.13701432dup nc_000005.8:g.13754432dup ng_013081.1:g.248164dup ng_013081.2:g.248164dup enst00000683611.1:n.791dup enst00000265104.5:c.13458dup enst00000681290.1:c.13413dup enst00000265104.4:c.13458dup nm_001369.2:c.13458dup xm_005248262.2:c.13413dup xm_005248262.3:c.13566dup xm_017009177.1:c.13146dup xm_017009178.1:c.12471dup xm_017009179.2:c.12471dup xm_017009185.1:c.8655dup xm_017009186.1:c.8208dup xm_017009188.1:c.7545dup xm_024454388.1:c.12471dup xm_024454389.1:c.12060dup nm_001369.3(dnah5):c.13458dup (p.asn4487ter)",
      "metCodes": [
        "PVS1",
        "PM3_Very Strong",
        "PP4"
      ],
      "metCodesSearch": "pvs1 pm3_very strong pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.13458dup (p.Asn4487Ter) is a frameshift variant that introduces a premature stop codon into exon 77 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.0001850, with 244 alleles / 1,179,964 total alleles in the European (non-Finnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.0001605 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 1 proband with primary ciliary dyskinesia who was homozygous for the variant (0.5 points, PMID: 16627867). This variant has also been reported in at least 4 probands with primary ciliary dyskinesia who were compound heterozygous with either the NM_001369.3(DNAH5):c.10815del (p.Pro3606fs) variant (PMID: 33479112), the NM_001369.3(DNAH5):c.3905del (p.Leu1302ArgfsTer19) variant (PMID: 16627867), the NM_001369.3(DNAH5):c.349dup (p.Glu117GlyfsTer18) variant (PMID: 38154480), or the NM_001369.3(DNAH5):c.13486C>T (p.Arg4496Ter) variant (PMID: 33479112, thesis of Mahmoud Fassad entitled \"Novel Gene Discovery in Primary Ciliary Dyskinesia\") confirmed in trans, which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (4 total points, PM3_Very Strong). At least one proband harboring this variant exhibits a phenotype including neonatal respiratory distress (1 pt), situs inversus (1 pt), sinusitis and otitis media (1 pt), and bronchiectasis (1 pt), as well as low nasal nitric oxide (1 pt), and an outer dynein arm defect detected by electron microscopy (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 6 points, PMID: 21270641, PP4). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM3_Very Strong, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "8d94dfc2-769e-4e2b-b2c9-e709ff616d2b",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013829",
      "_id": "AlleleRecords/1692900667",
      "_key": "1692900667",
      "_rev": "_mdBgI0u---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA501221",
      "classification": "Likely Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "228251",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.6249G>A",
        "NC_000005.10:g.13830026C>T",
        "CM000667.2:g.13830026C>T",
        "NC_000005.9:g.13830135C>T",
        "CM000667.1:g.13830135C>T",
        "NC_000005.8:g.13883135C>T",
        "NG_013081.1:g.119455G>A",
        "NG_013081.2:g.119455G>A",
        "ENST00000683090.1:n.1180G>A",
        "ENST00000265104.5:c.6249G>A",
        "ENST00000681290.1:c.6204G>A",
        "ENST00000265104.4:c.6249G>A",
        "NM_001369.2:c.6249G>A",
        "XM_005248262.2:c.6204G>A",
        "XM_011513990.1:c.6249G>A",
        "XR_925598.1:n.6456G>A",
        "XM_005248262.3:c.6357G>A",
        "XM_017009177.1:c.6357G>A",
        "XM_017009178.1:c.5262G>A",
        "XM_017009179.2:c.5262G>A",
        "XM_017009180.1:c.6357G>A",
        "XM_017009181.1:c.6357G>A",
        "XM_017009182.1:c.6357G>A",
        "XM_017009183.1:c.6357G>A",
        "XM_017009184.1:c.6357G>A",
        "XM_017009185.1:c.1446G>A",
        "XM_017009186.1:c.999G>A",
        "XM_017009187.1:c.6357G>A",
        "XM_017009188.1:c.336G>A",
        "XM_024454388.1:c.5262G>A",
        "XM_024454389.1:c.4851G>A",
        "XR_001742034.1:n.6374G>A",
        "XR_001742035.1:n.6374G>A",
        "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile)"
      ],
      "hgvsSearch": "nm_001369.3:c.6249g>a nc_000005.10:g.13830026c>t cm000667.2:g.13830026c>t nc_000005.9:g.13830135c>t cm000667.1:g.13830135c>t nc_000005.8:g.13883135c>t ng_013081.1:g.119455g>a ng_013081.2:g.119455g>a enst00000683090.1:n.1180g>a enst00000265104.5:c.6249g>a enst00000681290.1:c.6204g>a enst00000265104.4:c.6249g>a nm_001369.2:c.6249g>a xm_005248262.2:c.6204g>a xm_011513990.1:c.6249g>a xr_925598.1:n.6456g>a xm_005248262.3:c.6357g>a xm_017009177.1:c.6357g>a xm_017009178.1:c.5262g>a xm_017009179.2:c.5262g>a xm_017009180.1:c.6357g>a xm_017009181.1:c.6357g>a xm_017009182.1:c.6357g>a xm_017009183.1:c.6357g>a xm_017009184.1:c.6357g>a xm_017009185.1:c.1446g>a xm_017009186.1:c.999g>a xm_017009187.1:c.6357g>a xm_017009188.1:c.336g>a xm_024454388.1:c.5262g>a xm_024454389.1:c.4851g>a xr_001742034.1:n.6374g>a xr_001742035.1:n.6374g>a nm_001369.3(dnah5):c.6249g>a (p.met2083ile)",
      "metCodes": [
        "PS3_Supporting",
        "PM3_Strong",
        "PP1",
        "PP3",
        "PP4"
      ],
      "metCodesSearch": "ps3_supporting pm3_strong pp1 pp3 pp4",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.6249G>A (p.Met2083Ile) is a potential missense variant that is predicted to replace methionine with isoleucine at amino acid 2083, but is also located in the final nucleotide of exon 37. The computational predictor REVEL gives a score of 0.640, which is below the ClinGen Motile Ciliopathy VCEP threshold of ≥0.690 and does not predict a damaging effect on DNAH5 function. The splicing impact predictor SpliceAI gives delta scores of 0.84 for donor loss and 0.81 for acceptor loss, which are above the ClinGen Motile Ciliopathy VCEP recommended threshold of ≥0.2 and predict a damaging impact on DNAH5 splicing (PP3). RT-PCR analysis of patient mRNA showed that this variant causes a splicing defect that results in out-of-frame skipping of either exon 37 alone or exons 36 and 37 together, both of which are predicted to introduce a premature termination codon. The patient is compound heterozygous and harbors the variant in only half of the transcripts, so normally spliced mRNA is also present in the sample and may complicate attempts to accurately assess whether any normally spliced mRNA is produced from the variant allele (PMID: 23261302, PS3_Supporting). This variant is present in gnomAD v.4.1.1 at a Grpmax allele frequency of 0.00006643, with 94 alleles / 1,179,576 total alleles in the European (non-FInnish) population, which is lower than the BS1 threshold of >0.0006. The variant has a total allele frequency of 0.00006199 combined across all populations, which is higher than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006, so no population code is met. This variant is a known founder with relatively high rates of heterozygous occurrence in the control population, and is considered eligible for inclusion in the PM3 code despite not meeting PM2_Supporting. This variant has been reported in at least 5 probands with primary ciliary dyskinesia, one of whom was compound heterozygous with the NM_001369.3(DNAH5):c.2261dup (p.Met754fs) variant confirmed in trans, which was previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (1 point, PMID: 23261302). Two other probands with primary ciliary dyskinesia were compound heterozygous with either the NM_001369.3(DNAH5):c.3905del (p.Leu1302fs) variant or the NM_001369.3(DNAH5):c.8404C>T (p.Gln2802Ter) variant suspected but not reported as confirmed in trans (1 total point, PMID: 30067075, PMID: 33479112), both of which were previously classified pathogenic by the ClinGen Motile Ciliopathy VCEP (2 total points, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including diagnosis of primary ciliary dyskinesia with situs inversus (1 pt) and outer dynein arm defects (4 pts), family history consistent with autosomal recessive inheritance, low nasal nitric oxide (1 pt), recurrent otitis media and sinusitis (1 pt), and bronchiectasis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 8 points, PMID: 23261302, PP4). Genotyping by whole exome sequencing identified no alternative basis for disease but did not include all genes now known to be associated with primary ciliary dyskinesia with outer dynein arm defects. The variant has been reported to co-segregate with primary ciliary dyskinesia through at least one segregation within the family of the proband, with the variant present in the compound heterozygous state (PMID: 23261302, PP1). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PP3, PS3_Supporting, PM3_Strong, PP1, and PP4. (VCEP specifications version 1.0.0).",
      "unMetCodes": [
        "PM2",
        "BS1"
      ],
      "unMetCodesSearch": "pm2 bs1",
      "uuid": "84d4f2eb-b77d-4678-9cd9-a3700328075a",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013830",
      "_id": "AlleleRecords/1692901844",
      "_key": "1692901844",
      "_rev": "_mdBolZu---",
      "affiliationId": "50161",
      "approvedDate": "2026-11-18",
      "caId": "CA359196177",
      "classification": "Pathogenic",
      "condition": "primary ciliary dyskinesia 3",
      "cvId": "454760",
      "docVersion": "1.0.0",
      "ep": "Motile Ciliopathy VCEP",
      "gene": "DNAH5",
      "geneNcbiId": "1767",
      "hgvs": [
        "NM_001369.3:c.2710G>T",
        "NC_000005.10:g.13885997C>A",
        "CM000667.2:g.13885997C>A",
        "NC_000005.9:g.13886106C>A",
        "CM000667.1:g.13886106C>A",
        "NC_000005.8:g.13939106C>A",
        "NG_013081.1:g.63484G>T",
        "NG_013081.2:g.63484G>T",
        "ENST00000265104.5:c.2710G>T",
        "ENST00000681290.1:c.2665G>T",
        "ENST00000265104.4:c.2710G>T",
        "NM_001369.2:c.2710G>T",
        "XM_005248262.2:c.2665G>T",
        "XM_011513990.1:c.2710G>T",
        "XR_925598.1:n.2917G>T",
        "XM_005248262.3:c.2818G>T",
        "XM_017009177.1:c.2818G>T",
        "XM_017009178.1:c.1723G>T",
        "XM_017009179.2:c.1723G>T",
        "XM_017009180.1:c.2818G>T",
        "XM_017009181.1:c.2818G>T",
        "XM_017009182.1:c.2818G>T",
        "XM_017009183.1:c.2818G>T",
        "XM_017009184.1:c.2818G>T",
        "XM_017009187.1:c.2818G>T",
        "XM_024454388.1:c.1723G>T",
        "XM_024454389.1:c.1312G>T",
        "XR_001742034.1:n.2835G>T",
        "XR_001742035.1:n.2835G>T",
        "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter)"
      ],
      "hgvsSearch": "nm_001369.3:c.2710g>t nc_000005.10:g.13885997c>a cm000667.2:g.13885997c>a nc_000005.9:g.13886106c>a cm000667.1:g.13886106c>a nc_000005.8:g.13939106c>a ng_013081.1:g.63484g>t ng_013081.2:g.63484g>t enst00000265104.5:c.2710g>t enst00000681290.1:c.2665g>t enst00000265104.4:c.2710g>t nm_001369.2:c.2710g>t xm_005248262.2:c.2665g>t xm_011513990.1:c.2710g>t xr_925598.1:n.2917g>t xm_005248262.3:c.2818g>t xm_017009177.1:c.2818g>t xm_017009178.1:c.1723g>t xm_017009179.2:c.1723g>t xm_017009180.1:c.2818g>t xm_017009181.1:c.2818g>t xm_017009182.1:c.2818g>t xm_017009183.1:c.2818g>t xm_017009184.1:c.2818g>t xm_017009187.1:c.2818g>t xm_024454388.1:c.1723g>t xm_024454389.1:c.1312g>t xr_001742034.1:n.2835g>t xr_001742035.1:n.2835g>t nm_001369.3(dnah5):c.2710g>t (p.glu904ter)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting",
        "PP4",
        "PM3"
      ],
      "metCodesSearch": "pvs1 pm2_supporting pp4 pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0012085",
      "preferredVarTitle": "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter)",
      "publishedDate": "2026-11-18",
      "retracted": false,
      "summaryDesc": "NM_001369.3(DNAH5):c.2710G>T (p.Glu904Ter) is a nonsense variant that introduces a premature stop codon into exon 18 of 79, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PMIDs: 16627867, 11788826; PVS1). This variant is present in gnomAD v.4.1.1 at a total allele frequency of 0.0000006199, with 1 allele / 1,613,220 total alleles combined across all populations, which is lower than the ClinGen Motile Ciliopathy VCEP PM2_Supporting threshold of <0.00006 (PM2_Supporting). This variant has been reported in at least 2 probands with primary ciliary dyskinesia who were homozygous for the variant (1 total point, PMID: 31765523, PMID: 31638833, PM3). This variant has also been reported in at least 1 proband with primary ciliary dyskinesia who was compound heterozygous with the NM_001369.3(DNAH5):c.9106-1G>A variant suspected but not confirmed in trans (PMID: 31772028), which has not been considered for PM3 in order to avoid circularity. At least one proband harboring this variant exhibits a phenotype including absence of outer dynein arms by immunofluorescence study (4 pts), neonatal respiratory distress (1 pt), sinusitis and chronic otitis media (1 pt), recurrent pneumonia (0.5 pts), and bronchiectasis (1 pt), which together are specific for primary ciliary dyskinesia 3 (total 7.5 points, PMID: 40558543). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive primary ciliary dyskinesia 3 based on the ACMG/AMP criteria applied, as specified by the ClinGen Motile Ciliopathy VCEP: PVS1, PM2_Supporting, PM3, and PP4. (VCEP specifications version 1.0.0).",
      "uuid": "d8b8221c-68cc-48ca-bb64-1223c74d0579",
      "versionsList": [
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013278",
      "_id": "AlleleRecords/1542073448",
      "_key": "1542073448",
      "_rev": "_mcrvTfO---",
      "affiliationId": "50100",
      "approvedDate": "2026-09-04",
      "caId": "CA412716882",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.245T>A",
        "NC_000023.11:g.38369824T>A",
        "CM000685.2:g.38369824T>A",
        "NC_000023.10:g.38229077T>A",
        "CM000685.1:g.38229077T>A",
        "NC_000023.9:g.38114021T>A",
        "NG_008471.1:g.22342T>A",
        "ENST00000039007.5:c.245T>A",
        "ENST00000643344.1:c.245T>A",
        "ENST00000039007.4:c.245T>A",
        "ENST00000465127.1:c.172-296297T>A",
        "ENST00000488812.1:n.337T>A",
        "NM_000531.5:c.245T>A",
        "XM_017029556.1:c.245T>A"
      ],
      "hgvsSearch": "nm_000531.6:c.245t>a nc_000023.11:g.38369824t>a cm000685.2:g.38369824t>a nc_000023.10:g.38229077t>a cm000685.1:g.38229077t>a nc_000023.9:g.38114021t>a ng_008471.1:g.22342t>a enst00000039007.5:c.245t>a enst00000643344.1:c.245t>a enst00000039007.4:c.245t>a enst00000465127.1:c.172-296297t>a enst00000488812.1:n.337t>a nm_000531.5:c.245t>a xm_017029556.1:c.245t>a",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.245T>A",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.245T>A (p.Leu82Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 2 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1 (PM2_Supporting). In summary, this variant meets the criteria for being classified as Likely Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting.",
      "uuid": "630bf32a-5038-4493-8fa8-a7906b77d6a3",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013279",
      "_id": "AlleleRecords/1542073827",
      "_key": "1542073827",
      "_rev": "_mcsdEa6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224503",
      "classification": "Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97135",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.216+1G>T",
        "NC_000023.11:g.38367430G>T",
        "CM000685.2:g.38367430G>T",
        "NC_000023.10:g.38226683G>T",
        "CM000685.1:g.38226683G>T",
        "NC_000023.9:g.38111627G>T",
        "NG_008471.1:g.19948G>T",
        "ENST00000039007.5:c.216+1G>T",
        "ENST00000643344.1:c.216+1G>T",
        "ENST00000039007.4:c.216+1G>T",
        "ENST00000465127.1:c.172-298691G>T",
        "ENST00000488812.1:n.308+1G>T",
        "NM_000531.5:c.216+1G>T",
        "XM_017029556.1:c.216+1G>T",
        "NM_000531.6(OTC):c.216+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.216+1g>t nc_000023.11:g.38367430g>t cm000685.2:g.38367430g>t nc_000023.10:g.38226683g>t cm000685.1:g.38226683g>t nc_000023.9:g.38111627g>t ng_008471.1:g.19948g>t enst00000039007.5:c.216+1g>t enst00000643344.1:c.216+1g>t enst00000039007.4:c.216+1g>t enst00000465127.1:c.172-298691g>t enst00000488812.1:n.308+1g>t nm_000531.5:c.216+1g>t xm_017029556.1:c.216+1g>t nm_000531.6(otc):c.216+1g>t",
      "metCodes": [
        "PVS1",
        "PP4_Moderate",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pp4_moderate pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.216+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "NM_000531.6(OTC):c.216+1G>T variant in the OTC gene affects the canonical donor splice site of intron 2 and is predicted to lead to an out of frame consequence and loss of function via nonsense mediated decay (PVS1). This variant is absent from gnomAD v4.1.1 (PM2_Supporting). One patient with this variant displayed features including Orotic aciduria (+1), Hyperammonemia, Hyperglutaminemia ( +0.5), 10% Liver enzyme activity (+2), which is highly specific for OTC deficiency (PP4_Moderate, 3.5 points, PMID: 12175783). In summary, this variant meets the criteria for being classified as Pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1, PM2_Supporting, PP4_Moderate).",
      "uuid": "9b07d8cd-b8fc-45fc-9f11-ff392d1fbf01",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000001190",
      "_id": "AlleleRecords/1573013067",
      "_key": "1573013067",
      "_rev": "_mcqrI_C---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA8815251",
      "classification": "Uncertain Significance",
      "condition": "glycogen storage disease II",
      "cvId": "501777",
      "docVersion": "1.7.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.4:c.1288G>A",
        "NC_000017.11:g.80108790G>A",
        "CM000679.2:g.80108790G>A",
        "NC_000017.10:g.78082589G>A",
        "CM000679.1:g.78082589G>A",
        "NC_000017.9:g.75697184G>A",
        "NG_009822.1:g.12235G>A",
        "LRG_673:g.12235G>A",
        "ENST00000570803.6:c.1288G>A",
        "ENST00000572080.2:c.1288G>A",
        "ENST00000577106.6:c.1288G>A",
        "ENST00000302262.8:c.1288G>A",
        "ENST00000302262.7:c.1288G>A",
        "ENST00000390015.7:c.1288G>A",
        "NM_000152.3:c.1288G>A",
        "LRG_673t1:c.1288G>A",
        "NM_001079803.1:c.1288G>A",
        "NM_001079804.1:c.1288G>A",
        "XM_005257193.1:c.1288G>A",
        "XM_005257194.3:c.1288G>A",
        "NM_001079803.2:c.1288G>A",
        "NM_001079804.2:c.1288G>A",
        "XM_005257193.2:c.1288G>A",
        "XM_005257194.4:c.1288G>A",
        "NM_000152.5:c.1288G>A",
        "NM_001079803.3:c.1288G>A",
        "NM_001079804.3:c.1288G>A",
        "NM_000152.4(GAA):c.1288G>A (p.Glu430Lys)"
      ],
      "hgvsSearch": "nm_000152.4:c.1288g>a nc_000017.11:g.80108790g>a cm000679.2:g.80108790g>a nc_000017.10:g.78082589g>a cm000679.1:g.78082589g>a nc_000017.9:g.75697184g>a ng_009822.1:g.12235g>a lrg_673:g.12235g>a enst00000570803.6:c.1288g>a enst00000572080.2:c.1288g>a enst00000577106.6:c.1288g>a enst00000302262.8:c.1288g>a enst00000302262.7:c.1288g>a enst00000390015.7:c.1288g>a nm_000152.3:c.1288g>a lrg_673t1:c.1288g>a nm_001079803.1:c.1288g>a nm_001079804.1:c.1288g>a xm_005257193.1:c.1288g>a xm_005257194.3:c.1288g>a nm_001079803.2:c.1288g>a nm_001079804.2:c.1288g>a xm_005257193.2:c.1288g>a xm_005257194.4:c.1288g>a nm_000152.5:c.1288g>a nm_001079803.3:c.1288g>a nm_001079804.3:c.1288g>a nm_000152.4(gaa):c.1288g>a (p.glu430lys)",
      "metCodes": [
        "PP4_Moderate",
        "PM2_Supporting",
        "PM3"
      ],
      "metCodesSearch": "pp4_moderate pm2_supporting pm3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.4(GAA):c.1288G>A (p.Glu430Lys)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1288G>A variant in GAA results in the missense substitution of glutamate by lysine at amino acid 430 (p.Glu430Lys). This variant has been identified in a patient with infantile onset Pompe disease based on his clinical symptoms of hypotonia, hypertrophic cardiomyopathy, and elevated CK and transaminases. He had no detectable GAA activity in fibroblasts, was CRIM-negative, and started enzyme replacement therapy at 3 months of age (PMID: 39161458) (PP4_Moderate). This individual is compound heterozygous for c.368G>A (p.Gly123Glu) and c.1288G>A (p.Glu430Lys) on one allele, confirmed in trans with c.693-2A>C (PMID: 39161458). The variant in cis, c.368G>A (p.Gly123Glu), has been classified as likely benign by the ClinGen LD VCEP, while c.693-2A>C has been classified as pathogenic (1 pt) (PM3). The highest population minor allele frequency in gnomAD v4.1.2. is 0.0002936 (22/74922 alleles) in the African/African American population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting).  The computational predictor REVEL gives a score of 0.577 which is neither above nor below the thresholds predicting a damaging (>0.7) or benign (<0.5) impact on GAA function. SpliceAI predicts no impact on splicing. There is a ClinVar entry for this variant (Variation ID: 501777). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PM3, PP4_Moderate, PM2_Supporting.",
      "unMetCodes": [
        "PP3",
        "BP4"
      ],
      "unMetCodesSearch": "pp3 bp4",
      "uuid": "68d0c25e-977d-4211-b166-3f52d076d6b1",
      "versionsList": [
        "1.7.0",
        "1.6.0",
        "1.5.0",
        "1.4.0",
        "1.3.0",
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000001748",
      "_id": "AlleleRecords/1573015418",
      "_key": "1573015418",
      "_rev": "_mcsT8iS---",
      "affiliationId": "50009",
      "approvedDate": "2026-10-20",
      "caId": "CA8815179",
      "classification": "Likely Pathogenic",
      "condition": "glycogen storage disease II",
      "cvId": "497032",
      "docVersion": "1.2.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.1130del",
        "NC_000017.11:g.80108543del",
        "CM000679.2:g.80108543del",
        "NC_000017.10:g.78082342del",
        "CM000679.1:g.78082342del",
        "NC_000017.9:g.75696937del",
        "NG_009822.1:g.11988del",
        "LRG_673:g.11988del",
        "ENST00000570803.6:c.1130del",
        "ENST00000572080.2:c.1130del",
        "ENST00000577106.6:c.1130del",
        "ENST00000302262.8:c.1130del",
        "ENST00000302262.7:c.1130del",
        "ENST00000390015.7:c.1130del",
        "NM_000152.3:c.1130del",
        "LRG_673t1:c.1130del",
        "NM_001079803.1:c.1130del",
        "NM_001079804.1:c.1130del",
        "XM_005257193.1:c.1130del",
        "XM_005257194.3:c.1130del",
        "NM_000152.4:c.1130del",
        "NM_001079803.2:c.1130del",
        "NM_001079804.2:c.1130del",
        "XM_005257193.2:c.1130del",
        "XM_005257194.4:c.1130del",
        "NM_001079803.3:c.1130del",
        "NM_001079804.3:c.1130del",
        "NM_000152.5(GAA):c.1130del (p.Gly377fs)"
      ],
      "hgvsSearch": "nm_000152.5:c.1130del nc_000017.11:g.80108543del cm000679.2:g.80108543del nc_000017.10:g.78082342del cm000679.1:g.78082342del nc_000017.9:g.75696937del ng_009822.1:g.11988del lrg_673:g.11988del enst00000570803.6:c.1130del enst00000572080.2:c.1130del enst00000577106.6:c.1130del enst00000302262.8:c.1130del enst00000302262.7:c.1130del enst00000390015.7:c.1130del nm_000152.3:c.1130del lrg_673t1:c.1130del nm_001079803.1:c.1130del nm_001079804.1:c.1130del xm_005257193.1:c.1130del xm_005257194.3:c.1130del nm_000152.4:c.1130del nm_001079803.2:c.1130del nm_001079804.2:c.1130del xm_005257193.2:c.1130del xm_005257194.4:c.1130del nm_001079803.3:c.1130del nm_001079804.3:c.1130del nm_000152.5(gaa):c.1130del (p.gly377fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.1130del (p.Gly377fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.1130del (p.Gly377AlafsTer15) variant in GAA is a frameshift variant that is predicted to cause a premature stop codon in exon 7 out of a total of 20 exons, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v4.1.0. is 0.00001356 (16/1179904 alleles) in the European non-Finnish population, which is lower than the ClinGen LD VCEP threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). This variant has been reported in one patient with a reported diagnosis of Pompe disease, however, no further clinical or laboratory data is provided (insufficient data to apply PP4 or PM3). This individual is compound heterozygous for the variant and c.1548G>A (p.Trp516Ter), phase unconfirmed (PMID: 36007526). There is a ClinVar entry for this variant (Variation ID: 497032). In summary, this variant meets the criteria to be classified as likely pathogenic for Pompe disease. The classification of this variant has been upgraded from Variant of Uncertain Significance to Likely Pathogenic based on the recommendations of the ClinGen Sequence Variant Interpretation Working Group, that a variant meeting PVS1 and PM2_Supporting is classified as Likely Pathogenic (https://clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf ).GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LD VCEP (Specifications Version 2.0): PVS1, PM2_Supporting.",
      "unMetCodes": [
        "PP4",
        "PM3"
      ],
      "unMetCodesSearch": "pp4 pm3",
      "uuid": "47478b30-7442-41c3-a8b7-9bccaf02ed15",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000004135",
      "_id": "AlleleRecords/1573025053",
      "_key": "1573025053",
      "_rev": "_mcpE6Fu---",
      "affiliationId": "50009",
      "approvedDate": "2026-11-17",
      "caId": "CA16607903",
      "classification": "Uncertain Significance",
      "condition": "glycogen storage disease II",
      "cvId": "392862",
      "docVersion": "1.1.0",
      "ep": "Lysosomal Diseases VCEP",
      "gene": "GAA",
      "geneNcbiId": "2548",
      "hgvs": [
        "NM_000152.5:c.2316G>T",
        "NC_000017.11:g.80117094G>T",
        "CM000679.2:g.80117094G>T",
        "NC_000017.10:g.78090893G>T",
        "CM000679.1:g.78090893G>T",
        "NC_000017.9:g.75705488G>T",
        "NG_009822.1:g.20539G>T",
        "LRG_673:g.20539G>T",
        "ENST00000570803.6:c.2316G>T",
        "ENST00000572080.2:c.*454G>T",
        "ENST00000577106.6:c.2316G>T",
        "ENST00000302262.8:c.2316G>T",
        "ENST00000302262.7:c.2316G>T",
        "ENST00000390015.7:c.2316G>T",
        "ENST00000573556.1:n.269G>T",
        "NM_000152.3:c.2316G>T",
        "LRG_673t1:c.2316G>T",
        "NM_001079803.1:c.2316G>T",
        "NM_001079804.1:c.2316G>T",
        "XM_005257193.1:c.2316G>T",
        "XM_005257194.3:c.2316G>T",
        "NM_000152.4:c.2316G>T",
        "NM_001079803.2:c.2316G>T",
        "NM_001079804.2:c.2316G>T",
        "XM_005257193.2:c.2316G>T",
        "XM_005257194.4:c.2316G>T",
        "NM_001079803.3:c.2316G>T",
        "NM_001079804.3:c.2316G>T",
        "NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)"
      ],
      "hgvsSearch": "nm_000152.5:c.2316g>t nc_000017.11:g.80117094g>t cm000679.2:g.80117094g>t nc_000017.10:g.78090893g>t cm000679.1:g.78090893g>t nc_000017.9:g.75705488g>t ng_009822.1:g.20539g>t lrg_673:g.20539g>t enst00000570803.6:c.2316g>t enst00000572080.2:c.*454g>t enst00000577106.6:c.2316g>t enst00000302262.8:c.2316g>t enst00000302262.7:c.2316g>t enst00000390015.7:c.2316g>t enst00000573556.1:n.269g>t nm_000152.3:c.2316g>t lrg_673t1:c.2316g>t nm_001079803.1:c.2316g>t nm_001079804.1:c.2316g>t xm_005257193.1:c.2316g>t xm_005257194.3:c.2316g>t nm_000152.4:c.2316g>t nm_001079803.2:c.2316g>t nm_001079804.2:c.2316g>t xm_005257193.2:c.2316g>t xm_005257194.4:c.2316g>t nm_001079803.3:c.2316g>t nm_001079804.3:c.2316g>t nm_000152.5(gaa):c.2316g>t (p.trp772cys)",
      "metCodes": [
        "PM2_Supporting",
        "PM5_Supporting",
        "PP3"
      ],
      "metCodesSearch": "pm2_supporting pm5_supporting pp3",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0009290",
      "preferredVarTitle": "NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000152.5:c.2316G>T variant in GAA is a missense variant predicted to cause substitution of Tryptophan by Cysteine at amino acid 772 (p.Trp772Cys). The highest population minor allele frequency in gnomAD v4.1.2. is 0.000001695 (2/1180018 alleles) in the European non-Finnish population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant and it has not been reported in the literature in any individuals with Pompe disease. The computational predictor REVEL gives a score of 0.942 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). Another missense variant c.2314T>C (p.Trp772Arg) (PMID: 31619483, 18757064, ClinVar ID: 552527) in the same codon has been classified as likely pathogenic for Pompe disease by the ClinGen LD VCEP (PM5_Supporting). There is a ClinVar entry for this variant (Variation ID: 392862). In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for Pompe disease based on the GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 2.0): PP3, PM2_Supporting, PM5_Supporting.",
      "unMetCodes": [
        "PS3",
        "PM3"
      ],
      "unMetCodesSearch": "ps3 pm3",
      "uuid": "118c8346-2b31-42f6-8ca9-24f4c03b5bc1",
      "versionsList": [
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013319",
      "_id": "AlleleRecords/1599510307",
      "_key": "1599510307",
      "_rev": "_mcsuMeG---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224567",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97180",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.386+2T>C",
        "NC_000023.11:g.38381431T>C",
        "CM000685.2:g.38381431T>C",
        "NC_000023.10:g.38240684T>C",
        "CM000685.1:g.38240684T>C",
        "NC_000023.9:g.38125628T>C",
        "NG_008471.1:g.33949T>C",
        "ENST00000039007.5:c.386+2T>C",
        "ENST00000643344.1:c.*136+2T>C",
        "ENST00000039007.4:c.386+2T>C",
        "ENST00000465127.1:c.172-284690T>C",
        "ENST00000488812.1:n.423+2T>C",
        "NM_000531.5:c.386+2T>C",
        "XM_017029556.1:c.386+2T>C",
        "NM_000531.6(OTC):c.386+2T>C"
      ],
      "hgvsSearch": "nm_000531.6:c.386+2t>c nc_000023.11:g.38381431t>c cm000685.2:g.38381431t>c nc_000023.10:g.38240684t>c cm000685.1:g.38240684t>c nc_000023.9:g.38125628t>c ng_008471.1:g.33949t>c enst00000039007.5:c.386+2t>c enst00000643344.1:c.*136+2t>c enst00000039007.4:c.386+2t>c enst00000465127.1:c.172-284690t>c enst00000488812.1:n.423+2t>c nm_000531.5:c.386+2t>c xm_017029556.1:c.386+2t>c nm_000531.6(otc):c.386+2t>c",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.386+2T>C",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.386+2T>C variant in the OTC gene affects the canonical donor/acceptor splice site in the 4th intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.24, -89bp; donor loss, score 0.94, -2bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) (Total points of +9.)",
      "uuid": "1bd7fb98-eb4b-4e9b-8a93-db94c74d3105",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013320",
      "_id": "AlleleRecords/1599510568",
      "_key": "1599510568",
      "_rev": "_mcs2oz6---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA224544",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "cvId": "97160",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.298+1G>T",
        "NC_000023.11:g.38369878G>T",
        "CM000685.2:g.38369878G>T",
        "NC_000023.10:g.38229131G>T",
        "CM000685.1:g.38229131G>T",
        "NC_000023.9:g.38114075G>T",
        "NG_008471.1:g.22396G>T",
        "ENST00000039007.5:c.298+1G>T",
        "ENST00000643344.1:c.298+1G>T",
        "ENST00000039007.4:c.298+1G>T",
        "ENST00000465127.1:c.172-296243G>T",
        "ENST00000488812.1:n.353+38G>T",
        "NM_000531.5:c.298+1G>T",
        "XM_017029556.1:c.298+1G>T",
        "NM_000531.6(OTC):c.298+1G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.298+1g>t nc_000023.11:g.38369878g>t cm000685.2:g.38369878g>t nc_000023.10:g.38229131g>t cm000685.1:g.38229131g>t nc_000023.9:g.38114075g>t ng_008471.1:g.22396g>t enst00000039007.5:c.298+1g>t enst00000643344.1:c.298+1g>t enst00000039007.4:c.298+1g>t enst00000465127.1:c.172-296243g>t enst00000488812.1:n.353+38g>t nm_000531.5:c.298+1g>t xm_017029556.1:c.298+1g>t nm_000531.6(otc):c.298+1g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6(OTC):c.298+1G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.298+1G>T variant in the OTC gene affects the canonical donor/acceptor splice site in the 2nd intron. The variant is predicted by SpliceAI to result in acceptor loss, score 0.65, -82bp; donor loss, score 0.92, -1bp (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as a Likely pathogenic variant for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1), Total points +9.",
      "uuid": "de3fd1f2-b5b7-4d60-9d99-33c6bcd9161c",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013321",
      "_id": "AlleleRecords/1599510806",
      "_key": "1599510806",
      "_rev": "_mctIAf2---",
      "affiliationId": "50100",
      "approvedDate": "2026-11-07",
      "caId": "CA412718254",
      "classification": "Likely Pathogenic",
      "condition": "ornithine carbamoyltransferase deficiency",
      "docVersion": "1.2.0",
      "ep": "Urea Cycle Disorders VCEP",
      "gene": "OTC",
      "geneNcbiId": "5009",
      "hgvs": [
        "NM_000531.6:c.313G>T",
        "NC_000023.11:g.38381356G>T",
        "CM000685.2:g.38381356G>T",
        "NC_000023.10:g.38240609G>T",
        "CM000685.1:g.38240609G>T",
        "NC_000023.9:g.38125553G>T",
        "NG_008471.1:g.33874G>T",
        "ENST00000039007.5:c.313G>T",
        "ENST00000643344.1:c.*63G>T",
        "ENST00000039007.4:c.313G>T",
        "ENST00000465127.1:c.172-284765G>T",
        "ENST00000488812.1:n.354-4G>T",
        "NM_000531.5:c.313G>T",
        "XM_017029556.1:c.313G>T"
      ],
      "hgvsSearch": "nm_000531.6:c.313g>t nc_000023.11:g.38381356g>t cm000685.2:g.38381356g>t nc_000023.10:g.38240609g>t cm000685.1:g.38240609g>t nc_000023.9:g.38125553g>t ng_008471.1:g.33874g>t enst00000039007.5:c.313g>t enst00000643344.1:c.*63g>t enst00000039007.4:c.313g>t enst00000465127.1:c.172-284765g>t enst00000488812.1:n.354-4g>t nm_000531.5:c.313g>t xm_017029556.1:c.313g>t",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "X-linked inheritance",
      "mondoId": "MONDO:0010703",
      "preferredVarTitle": "NM_000531.6:c.313G>T",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000531.6(OTC):c.313G>T (p.Gly105Ter) variant in the OTC gene is a nonsense variant predicted to cause a premature stop codon in biologically-relevant-exon 4/10 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). To our current knowledge, this variant has not been reported in affected individuals in the published literature. In summary, this variant meets the criteria for being classified as Likely pathogenic for OTC deficiency. ACMG/AMP criteria applied, as specified by the ClinGen UCD VCEP Variant Interpretation Guidelines for OTC Version 1.0.0: PVS1 (+8), PM2_Supporting (+1) Total points +9.",
      "unMetCodes": [
        "PP4"
      ],
      "unMetCodesSearch": "pp4",
      "uuid": "ef323b86-4f21-4a7a-88a7-b5c7dfcf389e",
      "versionsList": [
        "1.2.0",
        "1.1.0",
        "1.0.0"
      ]
    },
    {
      "PCERDocID": "PCER000013762",
      "_id": "AlleleRecords/1692510770",
      "_key": "1692510770",
      "_rev": "_mchyX_m---",
      "affiliationId": "50052",
      "approvedDate": "2026-11-17",
      "caId": "CA16602267",
      "classification": "Likely Pathogenic",
      "condition": "HBA2-related alpha thalassemia spectrum",
      "cvId": "375744",
      "docVersion": "1.0.0",
      "ep": "Hemoglobinopathy VCEP",
      "gene": "HBA2",
      "geneNcbiId": "3040",
      "hgvs": [
        "NM_000517.6:c.94_95del",
        "NC_000016.10:g.173006_173007del",
        "CM000678.2:g.173006_173007del",
        "NC_000016.9:g.223005_223006del",
        "CM000678.1:g.223005_223006del",
        "NC_000016.8:g.163005_163006del",
        "NG_000006.1:g.33869_33870del",
        "NG_059186.1:g.1356_1357del",
        "NG_059271.1:g.5160_5161del",
        "ENST00000251595.11:c.94_95del",
        "ENST00000251595.10:c.94_95del",
        "ENST00000397806.1:c.-2+48_-2+49del",
        "ENST00000482565.1:n.113_114del",
        "ENST00000484216.1:n.63_64del",
        "NM_000517.4:c.94_95del",
        "NM_000517.6(HBA2):c.94_95del (p.Arg32fs)"
      ],
      "hgvsSearch": "nm_000517.6:c.94_95del nc_000016.10:g.173006_173007del cm000678.2:g.173006_173007del nc_000016.9:g.223005_223006del cm000678.1:g.223005_223006del nc_000016.8:g.163005_163006del ng_000006.1:g.33869_33870del ng_059186.1:g.1356_1357del ng_059271.1:g.5160_5161del enst00000251595.11:c.94_95del enst00000251595.10:c.94_95del enst00000397806.1:c.-2+48_-2+49del enst00000482565.1:n.113_114del enst00000484216.1:n.63_64del nm_000517.4:c.94_95del nm_000517.6(hba2):c.94_95del (p.arg32fs)",
      "metCodes": [
        "PVS1",
        "PM2_Supporting"
      ],
      "metCodesSearch": "pvs1 pm2_supporting",
      "moi": "Autosomal recessive inheritance",
      "mondoId": "MONDO:0100562",
      "preferredVarTitle": "NM_000517.6(HBA2):c.94_95del (p.Arg32fs)",
      "publishedDate": "2026-11-17",
      "retracted": false,
      "summaryDesc": "The NM_000517.6(HBA2).94_95del, p.(Arg32AspfsTer25) variant is a 2-bp deletion in the HBA2 gene, predicted to cause a frameshift and premature termination of the α-globin protein [PVS1]. To date, this variant has been reported in the literature in the context of the HBA2–HBA1 fusion gene resulting from the −α³·⁷ deletion (IthaGenes ID: 365; PMIDs: 2831226, 22187958).\nThe variant has been reported in individuals with HbH disease, including an individual with Hb G-Philadelphia–HbH disease and two unrelated individuals carrying the −α³·⁷ deletion on the homologous chromosome [PMIDs: 2831226, 22187958]. Hemoglobin biosynthesis analysis revealed altered α/β-globin synthesis ratios in individuals with related α-globin genotypes [PMID: 6935689]. However, these findings do not establish the independent functional impact of c.94_95del, and PS3_P was therefore not applied. The variant is absent from gnomAD v4.1.2 [PM2_Supporting].\nIn summary, this variant is classified as Likely Pathogenic for HBA2-related alpha thalassemia spectrum diseases (MONDO:0100562) in an autosomal recessive manner, based on the ACMG/AMP criteria as specified by the ClinGen Hemoglobinopathy VCEP (specification version 1.0.0): PVS1, PM2_Supporting. This classification follows the ClinGen SVI Recommendation for Absence/Rarity (PM2), Version 1.0 (September 4, 2020), which supports a Likely Pathogenic classification based on the combination of one Very Strong and one Supporting pathogenic criterion.",
      "unMetCodes": [
        "PS3",
        "PS4",
        "PM3"
      ],
      "unMetCodesSearch": "ps3 ps4 pm3",
      "uuid": "3867ca28-1827-49b5-941f-4c9e630db3d2",
      "versionsList": [
        "1.0.0"
      ]
    }
  ],
  "metadata": {
    "rendered": {
      "by": "https://erepo.genome.network/evrepo/api/summary/srvc",
      "when": "2026-11-19T11:21:33.860Z"
    }
  },
  "status": {
    "code": 200,
    "name": "OK"
  }
}